BEXIMCO PHARMACEUTICALS ANNOUNCES FLOTATION ON AIM

Beximco Pharmaceuticals Limited ("BPL" or the "Company"), a Bangladesh based and listed pharmaceuticals manufacturer, today announces that it is to list on AIM having successfully completed an institutional placing of global depositary receipts ("GDRs"). The placing has raised around US$21 million (£12 million) (before expenses) for the Company, giving it a post-money market capitalisation of over US$100 million (£58 million) at the placing price. Libertas Capital is acting as nominated adviser and broker to BPL, which will be one of the first companies to have GDRs trading on AIM.

Biotech Intelligence (http://www.biotech-intelligence.com/html/html/15ddd63a0caf6bd2e44e654248062c80.html)